Baker Avenue Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$1.77K	–	397
2023 Q3	$1.77K	Buy	10 +3	+43%	+$531	﹤0.01%	1150
2023 Q2	$1.33K	Sell	7 -2	-22%	-$380	﹤0.01%	1078
2023 Q1	$1.8K	Sell	9 -5	-36%	-$1K	﹤0.01%	1007
2022 Q4	$3.33K	Buy	+14	New	+$3.33K	﹤0.01%	862